Cardiomyopathy Trial, Recruiting (NCT07420907)

Cardiomyopathy Trial, Recruiting NCT07420907 Sponsor: Prolaio Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT07420907 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You are able to understand the study and agree to have your data collected
You are able to follow the study rules and schedule
You are able to understand and respond to instructions given in English
You have been diagnosed with a qualifying heart or blood vessel condition, such as heart failure, aortic stenosis, hypertrophic cardiomyopathy, high blood pressure, dilated cardiomyopathy, or similar conditions (confirm with trial site for full list)
You currently live in the United States

Who may not be able to join:

You have an allergy to the adhesive (sticky material) used in stick-on sensor patches
You have a serious life-threatening illness unrelated to heart conditions, such as active cancer, liver failure, end-stage kidney disease, or you are waiting for or have recently had an organ transplant
You have very severe heart disease, meaning you were admitted to hospital for a heart-related reason within the last 30 days, or your heart condition severely limits all physical activity (confirm with trial site)
You self-report your weight as 400 pounds or more

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 1-855-869-9054

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07420907

Sponsor: Prolaio

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: 1-855-869-9054

More information: https://clinicaltrials.gov/study/NCT07420907

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You are able to understand the study and agree to have your data collected
You are able to follow the study rules and schedule
You are able to understand and respond to instructions given in English
You have been diagnosed with a qualifying heart or blood vessel condition, such as heart failure, aortic stenosis, hypertrophic cardiomyopathy, high blood pressure, dilated cardiomyopathy, or similar conditions (confirm with trial site for full list)
You currently live in the United States

Who may not be able to join:

You have an allergy to the adhesive (sticky material) used in stick-on sensor patches
You have a serious life-threatening illness unrelated to heart conditions, such as active cancer, liver failure, end-stage kidney disease, or you are waiting for or have recently had an organ transplant
You have very severe heart disease, meaning you were admitted to hospital for a heart-related reason within the last 30 days, or your heart condition severely limits all physical activity (confirm with trial site)
You self-report your weight as 400 pounds or more

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Prolaio

Registry

ClinicalTrials.gov

Start date

30 October 2025

Est. completion

1 October 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Longitudinal Assessment of Clinical Status; Longitudinal Assessment of Clinical Status; Longitudinal Assessment of Clinical Status; Longitudinal Assessment of Clinical Status

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov